Word: cancerously
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...years after a landmark federal study established that hormone-replacement therapy (HRT) increases the risk of breast cancer in postmenopausal women, researchers are still trying to tease out exactly how the hormones interfere with women's health. The assumption has always been that stopping hormone therapy would lead to a corresponding drop in breast-cancer risk, but now newly published data from the original trial - the multiyear Women's Health Initiative involving tens of thousands of women - suggest that the benefit occurs much more immediately than previously thought...
...finding is a contentious one. The authors of the new paper, which appears in the Feb. 5 issue of the New England Journal of Medicine, found that the rate of breast cancer in postmenopausal women fell just two years after they stopped hormone therapy and continued to decline yearly. In addition, researchers found that women taking supplemental estrogen and progestin had doubled their risk of breast cancer after five years, compared with women not taking...
...question is why. The authors hypothesize that the decline in breast cancer rates was largely due to the sudden stoppage of hormone therapy. But this correlation, first presented at the San Antonio Breast Cancer Conference in December, has been met with skepticism by other researchers in the community. They raised concerns about drawing a cause-and-effect relationship, since the sharpest decline in women's breast cancer rates occurred in the year after the WHI was halted and its data released, between 2002 and 2003 - too soon to see such a dramatic change in a complex disease like breast cancer...
...other half of the donation will support the work of Harvard Medical School assistant professors Catherine J. Wu and Nir Hacohen at the Eli and Edythe L. Broad Institute, where the two research cancer vaccines...
...foundation. Greece has lost one of her most distinguished daughters. The international world of Byzantine studies has lost its most excellent historian,” said history Professor Michael McCormick. “Harvard has lost all of this and something more.” Laiou died of thyroid cancer at Mass. General Hospital in December. She was 67. As a scholar, Laiou spearheaded research in Mediterranean economic history and women’s history, and her 1985 appointment to lead the History department made her the first female chair of a department at Harvard...